d-Sotalol Induces Marked Action Potential Prolongation and Early Afterdepolarizations in M but Not Epicardial or Endocardial Cells of the Canine Ventricle
- 1 March 1997
- journal article
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 2 (1) , 27-37
- https://doi.org/10.1177/107424849700200104
Abstract
Background: Despite its class III antiarrhythmic actions, experimental and clinical studies have shown that d-sotalol can also be proarrhythmic; a recent clinical trial that evaluated d- sotalol in postmyocardial patients (SWORD) had to be prematurely interrupted because of the excess mortality in the treated group. Previous studies have demonstrated the existence of a marked heterogeneity across the ventricular wall; epicardial, endocardial, and M cells have been shown to display distinct electrophysiologic characteristics and pharmacologic behav ior. The present study was designed to test the hypothesis that M cells are the primary target for the class III actions of d-sotalol in canine ventricular myocardium and may contribute to its proarrhythmic effects.Keywords
This publication has 48 references indexed in Scilit:
- Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordingsThe American Journal of Cardiology, 1996
- Electrophysiologic and Antiarrhythmic Effects of D-SotalolJournal of Cardiovascular Pharmacology, 1992
- Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmiasThe American Journal of Cardiology, 1991
- Comparability of the Electrophysiologic Responses and Plasma and Myocardial Tissue Concentrations of Sotalol and its d Stereoisomer in the DogJournal of Cardiovascular Pharmacology, 1990
- Comparative Antifibrillatory Effects of d- and dl-Sotalol in Normal and Ischaemic Ventricular Muscle of the CatJournal of Cardiovascular Pharmacology, 1990
- Concentration/response relations for the multiple antiarrhythmic actions of sotalolThe American Journal of Cardiology, 1990
- Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.Circulation, 1986
- d-Sotalol: a new potent class III anti-arrhythmic agentClinical Science, 1985
- A comparison of the cardiovascular effects of (+)‐sotalol and (+/‐)‐ sotalol following intravenous administration in normal volunteers.British Journal of Clinical Pharmacology, 1985
- Antiarrhythmic and Antifibrillatory Actions of the Levo- and Dextrorotatory Isomers of SotalolJournal of Cardiovascular Pharmacology, 1984